Liver Neoplasms [clinicaltrials_resource:8b0e0cfac4e116f7f7f5b4df7412c369]
A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver [clinicaltrials:NCT00001587]Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver [clinicaltrials:NCT00041808]Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma [clinicaltrials:NCT00051532]Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma [clinicaltrials:NCT00051545]Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases [clinicaltrials:NCT00068068]Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors [clinicaltrials:NCT00081848]Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases [clinicaltrials:NCT00083785]Study of NS-9 in Patients With Liver Metastases [clinicaltrials:NCT00094003]Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases [clinicaltrials:NCT00106054]Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) [clinicaltrials:NCT00122876]clinicaltrials:NCT00143403The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases [clinicaltrials:NCT00145665]Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver [clinicaltrials:NCT00149396]Orthotopic Liver Transplantation Using a Living Donor [clinicaltrials:NCT00152607]Stereotactic Radiotherapy (SRT) Liver (COLD 1) [clinicaltrials:NCT00152906]Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation [clinicaltrials:NCT00178243]Qidong Hepatitis B Intervention Study [clinicaltrials:NCT00222664]clinicaltrials:NCT00247676Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases [clinicaltrials:NCT00327652]Genetic Susceptibility to Oncogenic Viruses [clinicaltrials:NCT00341484]A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) [clinicaltrials:NCT00355355]HAI Via Interventionally Implanted Port Catheter Systems [clinicaltrials:NCT00356161]Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis [clinicaltrials:NCT00392366]A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver [clinicaltrials:NCT00441376]clinicaltrials:NCT00470340Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors [clinicaltrials:NCT00493883]Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation [clinicaltrials:NCT00584402]clinicaltrials:NCT00659022Quality of Life After Liver Resection [clinicaltrials:NCT00681499]Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector [clinicaltrials:NCT00763776]SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization [clinicaltrials:NCT00788697]SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization [clinicaltrials:NCT00829413]Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer [clinicaltrials:NCT00922181]clinicaltrials:NCT01009593CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer [clinicaltrials:NCT01033240]clinicaltrials:NCT01043523clinicaltrials:NCT01098422clinicaltrials:NCT01099631Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors [clinicaltrials:NCT01177007]clinicaltrials:NCT01214343
condition [clinicaltrials_vocabulary:condition]
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver [clinicaltrials:NCT00001576]A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver [clinicaltrials:NCT00001587]Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer [clinicaltrials:NCT00002485]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer [clinicaltrials:NCT00002515]Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [clinicaltrials:NCT00002608]Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases [clinicaltrials:NCT00002655]Chemotherapy in Treating Patients With Liver Cancer [clinicaltrials:NCT00003044]Gene Therapy in Treating Patients With Cancer of The Liver [clinicaltrials:NCT00003147]Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer [clinicaltrials:NCT00003296]Tamoxifen in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00003424]Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]Antineoplaston Therapy in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00003530]clinicaltrials:NCT00003557Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [clinicaltrials:NCT00003714]clinicaltrials:NCT00003907Chemotherapy in Treating Children With Liver Cancer [clinicaltrials:NCT00003912]clinicaltrials:NCT00003926Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma [clinicaltrials:NCT00003958]Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer [clinicaltrials:NCT00003994]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]DX-8951f in Treating Patients With Liver Cancer [clinicaltrials:NCT00004108]Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer [clinicaltrials:NCT00004136]Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [clinicaltrials:NCT00004248]clinicaltrials:NCT00005629clinicaltrials:NCT00005997Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed [clinicaltrials:NCT00006006]clinicaltrials:NCT00006010Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery [clinicaltrials:NCT00006016]Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors [clinicaltrials:NCT00007813]clinicaltrials:NCT00009893Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer [clinicaltrials:NCT00012324]Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors [clinicaltrials:NCT00019331]Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [clinicaltrials:NCT00019474]Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas [clinicaltrials:NCT00019513]clinicaltrials:NCT00019604Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00019630]Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases [clinicaltrials:NCT00019786]Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors [clinicaltrials:NCT00020150]SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00020774]Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor [clinicaltrials:NCT00021047]
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver [clinicaltrials:NCT00001576]A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver [clinicaltrials:NCT00001587]Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer [clinicaltrials:NCT00002485]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer [clinicaltrials:NCT00002515]Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [clinicaltrials:NCT00002608]Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases [clinicaltrials:NCT00002655]Chemotherapy in Treating Patients With Liver Cancer [clinicaltrials:NCT00003044]Gene Therapy in Treating Patients With Cancer of The Liver [clinicaltrials:NCT00003147]Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer [clinicaltrials:NCT00003296]Tamoxifen in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00003424]Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]Antineoplaston Therapy in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00003530]clinicaltrials:NCT00003557Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer [clinicaltrials:NCT00003714]clinicaltrials:NCT00003907Chemotherapy in Treating Children With Liver Cancer [clinicaltrials:NCT00003912]clinicaltrials:NCT00003926Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma [clinicaltrials:NCT00003958]Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer [clinicaltrials:NCT00003994]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]DX-8951f in Treating Patients With Liver Cancer [clinicaltrials:NCT00004108]Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer [clinicaltrials:NCT00004136]Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [clinicaltrials:NCT00004248]clinicaltrials:NCT00005629clinicaltrials:NCT00005997Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed [clinicaltrials:NCT00006006]clinicaltrials:NCT00006010Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery [clinicaltrials:NCT00006016]Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors [clinicaltrials:NCT00007813]clinicaltrials:NCT00009893Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer [clinicaltrials:NCT00012324]Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors [clinicaltrials:NCT00019331]Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [clinicaltrials:NCT00019474]Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas [clinicaltrials:NCT00019513]clinicaltrials:NCT00019604Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00019630]Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases [clinicaltrials:NCT00019786]Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors [clinicaltrials:NCT00020150]SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer [clinicaltrials:NCT00020774]Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor [clinicaltrials:NCT00021047]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Liver Neoplasms [clinicaltrials_resource:8b0e0cfac4e116f7f7f5b4df7412c369]
Bio2RDF identifier
8b0e0cfac4e116f7f7f5b4df7412c369
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8b0e0cfac4e116f7f7f5b4df7412c369
identifier
clinicaltrials_resource:8b0e0cfac4e116f7f7f5b4df7412c369
title
Liver Neoplasms
@en
type
label
Liver Neoplasms [clinicaltrials_resource:8b0e0cfac4e116f7f7f5b4df7412c369]
@en
Liver Neoplasms